- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Severe Seborrheic Dermatitis in New Zealand
Total 802 results
-
Mimetica Pty LimitedCompletedSeborrhea | Oily SkinUnited States
-
Promius Pharma, LLCCompleted
-
Icahn School of Medicine at Mount SinaiIncyte CorporationCompleted
-
PeplinCompletedSeborrheic KeratosisAustralia
-
Icahn School of Medicine at Mount SinaiPfizerRecruitingSeborrheic Dermatitis | Papulopustular RosaceaUnited States
-
Medicis Global Service CorporationCompletedSeborrheic DermatitisUnited States
-
Arcutis Biotherapeutics, Inc.CompletedSeborrheic DermatitisUnited States, Canada
-
Arcutis Biotherapeutics, Inc.CompletedSeborrheic DermatitisUnited States
-
Tavotek BiotherapeuticsRecruiting
-
University of Auckland, New ZealandCompletedVaccinationNew Zealand
-
Ribon Therapeutics, Inc.RecruitingAtopic DermatitisAustralia, New Zealand
-
DermBiont, Inc.Active, not recruitingA Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic KeratosisSeborrheic KeratosisUnited States
-
Suzhou Connect Biopharmaceuticals, Ltd.CompletedModerate-to-severe Atopic DermatitisUnited States, Australia, China, New Zealand
-
Regeneron PharmaceuticalsSanofiCompletedModerate to Severe Atopic Hand and Foot DermatitisUnited States, Germany, Japan, Poland
-
Qurient Co., Ltd.CompletedModerate to Severe Atopic DermatitisUnited States
-
Inmagene LLCActive, not recruitingAtopic Dermatitis | Moderate-to-severe Atopic Dermatitis | ADCanada, United States
-
Sanofi Pasteur, a Sanofi CompanyUnited States Department of DefenseCompletedDengue | Dengue Fever | Dengue Hemorrhagic FeverUnited States
-
Galderma R&DCompletedModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Canada, Czechia, Germany, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Spain, United Kingdom
-
Aclaris Therapeutics, Inc.CompletedSeborrheic KeratosisUnited States
-
Galderma R&DActive, not recruitingModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Singapore, Spain, United Kingdom
-
Akesobio Australia Pty LtdCompletedAtopic DermatitisNew Zealand, Australia
-
SanofiRegeneron PharmaceuticalsRecruitingModerate to Severe Atopic DermatitisCanada
-
AmgenActive, not recruitingAtopic Dermatitis | Moderate-to-severe Atopic DermatitisUnited States, Canada
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.CompletedModerate to Severe Atopic DermatitisUnited States, Canada, Czechia, Germany, Poland
-
Regeneron PharmaceuticalsSanofiRecruitingModerate-to-Severe Atopic Dermatitis | Atopic EczemaUnited States
-
Galderma R&DRecruitingModerate-to-Severe Atopic DermatitisUnited States, Denmark, Hungary, Poland, Spain
-
University of SouthamptonNational University Hospital, Singapore; Singapore Institute for Clinical Sciences and other collaboratorsEnrolling by invitationNeurobehavioral Manifestations | Allergy | Microbial Colonization | Growth Disorders | Atopic Dermatitis | Obesity, Childhood | Metabolic Disturbance | Cognition | Lifestyle | Breastfeeding | Nutrition, Healthy | AtopySingapore, United Kingdom, New Zealand
-
Regeneron PharmaceuticalsSanofiCompletedAtopic DermatitisGermany, New Zealand, Australia
-
Galderma R&DCompletedModerate-to-Severe Atopic DermatitisUnited States, Belgium, Bulgaria, Estonia, France, Georgia, Germany, Hungary, Italy, Poland, Singapore
-
Sanofi Pasteur, a Sanofi CompanyCompletedDengue | Dengue Fever | Dengue Hemorrhagic FeverIndia
-
Nektar TherapeuticsRecruitingModerate to Severe Atopic DermatitisUnited States, Canada
-
Zealand University HospitalUniversity of Copenhagen; Danish Working Environment FundCompleted
-
Sanofi Pasteur, a Sanofi CompanyCompletedDengue | Dengue Fever | Dengue Hemorrhagic FeverIndia
-
SanofiCompletedDengue Fever | Dengue Hemorrhagic Fever | Dengue VirusUnited States
-
Regeneron PharmaceuticalsSanofiCompletedHypersensitivity, Immediate | Dermatitis, Atopic | Moderate-to-Severe Atopic Dermatitis | Dermatitis, Dermatitis Atopic | Eczema, Skin Diseases, Skin | Diseases Genetic, Genetic | Diseases Inborn, Skin | Disease, Eczematous Skin | Hypersensitivity, Immune System DiseasesUnited States, Canada
-
NeuroActiva, Inc.Biomed Industries, Inc.UnknownCovid19 | SARS-CoV-2 | SARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome)New Zealand, United States
-
Rockefeller UniversityWashington University School of Medicine; Tel Aviv UniversityCompleted
-
BayerCompleted
-
MC2 TherapeuticsCompletedPhototoxicityUnited States
-
Akesobio Australia Pty LtdRecruitingPhase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic DermatitisAtopic DermatitisUnited States, Australia, New Zealand
-
AnaptysBio, Inc.RecruitingAtopic Dermatitis EczemaUnited States, Canada, Georgia, New Zealand
-
Botanix PharmaceuticalsCompletedAtopic DermatitisUnited States, Australia, New Zealand
-
MedImmune LLCAmgenCompletedAtopic DermatitisUnited States, Germany, New Zealand, Hungary, Australia, Canada